Evidence map›Paper›PMID 42270899›Full record

ArticleScientific reports2026

A survey of respiratory physicians on investigating and managing tuberculous pleuritis.

Ken Ka Pang Chan, Hongtao Niu, Chin Chung Shu, Ying-Chun Chien, Larry Ellee Nyanti, Nai-Chien Huan, Cary Amiel G Villanueva, Aparna Chatterjee, Debraj Jash, Jack Kit Chung Ng and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ken Ka Pang ChanDepartment of Medicine & Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China. chankapang@cuhk.edu.hk.
Hongtao NiuState Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, Beijing, China.
Chin Chung ShuDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Ying-Chun ChienDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Larry Ellee NyantiMedical Department, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia.
Nai-Chien HuanDepartment of Respiratory Medicine, Queen Elizabeth Hospital, Kota Kinabalu, Sabah, Malaysia.
Cary Amiel G VillanuevaDivision of Pulmonary Medicine, Department of Medicine, Philippine General Hospital, University of the Philippines, Manila, Philippines.
Aparna ChatterjeeManipal Broadway Hospital, Kolkata, West Bengal, India.
Debraj JashManipal Broadway Hospital, Kolkata, West Bengal, India.
Jack Kit Chung NgDepartment of Medicine & Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China.
Kwun Cheung LingDepartment of Medicine & Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China.
Roland LeungDepartment of Medicine & Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China.
David Shu Cheong HuiDepartment of Medicine & Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China.
Pyng LeeDepartment of Medicine, National University of Singapore, Singapore, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnosing tuberculous pleuritis (TBP) is challenging. No consensus currently guides its workup and management in tuberculosis (TB)-endemic regions. An online survey was conducted to assess real-world practices of respiratory physicians when approaching new-onset unilateral pleural effusion and the likelihood of TBP being considered in the diagnostic workup. Responses from 414 respiratory physicians across 15 countries/regions were analyzed, with 98.8% from intermediate-to-high TB burden areas. TBP was frequently considered as a differential diagnosis for new-onset unilateral pleural effusion by 80.4% of respondents. Heterogeneity was observed in the diagnostic and therapeutic approaches among respondents. Initial investigations, including pleural fluid Mycobacterium tuberculosis (MTB) culture, adenosine deaminase and pleural biopsy for histology, were performed variably. Selection of TBP-specific diagnostic tests was correlated with regional TB burden and initial consideration of TBP. Varied perceptions of diagnostic test accuracy were also evident among respondents. A definitive TBP diagnosis, supported by histological or microbiological proof, was required by 60.9% of respondents before anti-TB treatment was initiated. 77.8% of respondents had experienced a revision of the diagnosis of probable TBP cases following empirical anti-TB treatment failure. These findings highlight the need to strengthen the diagnosis and management of TBP in surveyed regions.

Indexed as

PhysiciansTuberculosis, PleuralAdenosine DeaminaseAntitubercular AgentsDiagnosis, DifferentialFemaleHumansMycobacterium tuberculosisPleural EffusionSurveys and QuestionnairesAdenosine DeaminaseAntitubercular AgentsAdenosine deaminaseMycobacterium tuberculosisPleural effusionSurveyTuberculous pleuritis

Identifiers

PMID42270899
PMCPMC13503735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.